Barrett's esophagus (BE) is a rapidly increasing preneoplastic disorder that arises in the setting of chronic inflammation and repeated injury from acid and bile reflux. While the histopathologic progression of BE to EAC has been well characterized, the cell of origin for BE has been poorly understood. Recent studies have focused on the possibility of transdifferentiation of squamous epitheilial progenitors, but work from our group has pointed to progenitors that reside in the gastric cardia. Using a newly created L2-IL-1beta transgenic mouse model of BE/EAC, in which IL-1 beta is over expressed in the esophageal squamous mucosa, we have observed an early upregulation of progenitors expressing Lgr5, Cck2r, and Dclkl in the proximal stomach just below the squamocolumnar junction (SCJ). These progenitors, which are absent in normal esophageal squamous mucosa, are amplified first in the gastric cardia by inflammation and bile acids, and migrate over time proximally into the SCJ in association with expansion of BE. These progenitors are also absent from normal human squamous esophageal epithelium but markedly upregulated in human Barrett's. Preliminary studies by our group using inducible Cre-ERT2 mice have shown that Lgr5 and Cck2r mark active stem or progenitor cells In the cardia, while Dclkl marks a long-lived quiescent stem cell in the gastric cardia. Based on these studies, we propose three specific aims: (1) What is the role of active (Lgr5+ or Cck2r+) stenri/progenitor cells present in the cardia in the development of Barrett's esophagus in the mouse? Lineage tracing studies of Lgr5+ and Cck2r+ progenitors will be performed in the normal gastic cardia, in the BE/EAC lesions in the L2-lL-1b mouse, and in the surgical reflux (esophagojejunostomy) model of BE. (2), What is the role of quiescent (Dclkl) stem cells present in the cardia in the development of BE in the mouse? Both constitutive and inducible lines of Dclkl-Cre mice will be used in lineage tracing studies, and the relationship to other progenitors explored, (3). Does administration of YF476 (a Cck2r-specific antagonist) to human patients with BE inhibit cellular proliferation? We will carry out a pilot clinical trial to determine if targeting cardia progenitors early on may represent a potential chemoprevention strategy.

Public Health Relevance

This study is an attempt at lineage tracing of progenitors in a murine model of Barrett's esophagus in order to establish the cellular origins of the disorder. In addition, we will attempt to target these cardia progenitors using an antagonist specific to receptors present on these cells. We hypothesize that inhibiting receptors expressed by gastric cardia sterp cells may represent a potential strategy to prevent BE progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163004-03
Application #
8535696
Study Section
Special Emphasis Panel (ZCA1-SRLB-1)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
3
Fiscal Year
2013
Total Cost
$195,267
Indirect Cost
$49,422
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Fecteau, Ryan E; Kong, Jianping; Kresak, Adam et al. (2016) Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia. JAMA Oncol 2:1333-1339
Critchley-Thorne, Rebecca J; Duits, Lucas C; Prichard, Jeffrey W et al. (2016) A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 25:958-68
Bansal, Ajay; Gupta, Vijayalaxmi; Wang, Kenneth (2016) MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus. J Cell Biochem 117:1288-95
Chan, Daniel K; Leggett, Cadman L; Wang, Kenneth K (2016) Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. World J Gastroenterol 22:1639-49
Schellnegger, Raphael; Quante, Anne; Rospleszcz, Susanne et al. (2016) Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma. Cancer Prev Res (Phila) :
Kong, Jianping; Whelan, Kelly A; Laczkó, Dorottya et al. (2016) Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress. Mol Carcinog 55:1526-1541
Snider, Erik J; Freedberg, Daniel E; Abrams, Julian A (2016) Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 61:2217-25
Pattison, Amanda M; Blomain, Erik S; Merlino, Dante J et al. (2016) Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins. Infect Immun 84:3083-91
Small, Aaron J; Sutherland, Scott E; Hightower, Jessica S et al. (2015) Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus. Gastrointest Endosc 81:1158-66.e1-4
Stachler, Matthew D; Taylor-Weiner, Amaro; Peng, Shouyong et al. (2015) Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet 47:1047-55

Showing the most recent 10 out of 43 publications